Comparison of infusion or low-dose proton pump inhibitor treatments in upper gastrointestinal system bleeding

European Journal of Internal Medicine

Volumn 22, Issue 2, 2011, Pages 200-204

  Songür, Yildiran ^a   Balkarli, Ayşe ^a   Acartürk, Gürsel ^a   Şenol, Altug ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

Author keywords

Bleeding; Infusion; Low dose; Proton pump inhibitor; Re bleeding; Treatment; Ulcer

Indexed keywords

ESOMEPRAZOLE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; FEMALE; GASTROINTESTINAL ENDOSCOPY; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LOADING DRUG DOSE; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; PEPTIC ULCER; UPPER GASTROINTESTINAL BLEEDING;

AGED; BLOOD TRANSFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMOSTASIS, ENDOSCOPIC; HOSPITALIZATION; HUMANS; INFUSIONS, INTRAVENOUS; LENGTH OF STAY; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER; PROSPECTIVE STUDIES; PROTON PUMPS; RECURRENCE; UPPER GASTROINTESTINAL TRACT; VASCULAR SURGICAL PROCEDURES;

EID: 79952699734     PISSN: 09536205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejim.2010.11.007     Document Type: Article

References (22)

1. Jensen DM, Kovacs TO, Jutabha R, Machicado GA, Gralnek IM, Savides TJ, et al. Randomized trial of medical or endoscopic therapy to prevent recurrent ulcer hemorrhage in patients with adherent clots. Gastroenterology 2002;123:407-13. (Pubitemid 34827184)
2. Esrailian E, Gralnek IM. Nonvariceal upper gastrointestinal bleeding: epidemiology and diagnosis. Gastroenterol Clin North Am 2005;34:589-605. (Pubitemid 41643121)
3. Laine L, Peterson WL. Bleeding peptic ulcer. N Engl J Med 1994;331:717-27. (Pubitemid 24275746)
4. Barkun AN, Cockeram AW, Plourdea V, Fedorak RN. Review article: acid suppression in non-variceal acute upper gastrointestinal bleeding. Aliment Pharmacol Ther 1999;13:1565-84. (Pubitemid 30009074)
5. Branicki FJ, Coleman SY, Fok PJ, Pritchett CJ, Fan ST, Lai EC, et al. Bleeding peptic ulcer: a prospective evaluation of risk factors for rebleeding and mortality. World J Surg 1990;14:262-9.
6. Vreeburg EM, Terwee CB, Snel P, Rauws EA, Bartelsman JF, Meulen JH, et al. Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut 1999;44:331-5. (Pubitemid 29119326)
7. Hsu PI, Lai KH, Lin XZ, Yang YF, Lin M, Shin JS, et al. When to discharge patients with bleeding peptic ulcers: a prospective study of residual risk of rebleeding. Gastrointest Endosc 1996;44:382-7. (Pubitemid 26347834)
8. Green Jr FW. Kaplan MM, Curtis LE, Levine PH. Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage. Gastroenterology 1978;74:38-43.
9. Patchett SE, Enright H, Afdhal N, O'Connell W, O'Donoghue DP. Clot lysis by gastric juice: An in vitro study. Gut 1989;30:1074-7.
10. Hasselgren G, Lind T, Lundell L, Aadland E, Efskind P, Falk A, et al. Continuous intravenous infusion of omeprazole in elderly patients with peptic ulcer bleeding. Results of a placebo-controlled multicenter study. Scand J Gastroenterol 1997;32:328-33. (Pubitemid 27156169)
11. Lin HJ, Lo WC, Lee FY, Perng CL, Tseng GY. A prospective randomized comparative trial showing that omeprazole prevents rebleeding in patients with bleeding peptic ulcer after successful endoscopic therapy. Arch Intern Med 1998;158:54-8.
12. Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, et al. Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 2000;343:310-6. (Pubitemid 30616696)
13. Rockall TA, Logan RF, Devlin HB, Northfield TC. Risk assessment after acute upper gastrointestinal haemorrhage. Gut 1996;38:316-21. (Pubitemid 26074312)
14. Hamoui N, Docherty SD, Crookes PF. Gastrointestinal hemorrhage: is the surgeon obsolete. Emerg Med Clin North Am 2003;21:1017-56.
15. British Society of Gastroenterology Endoscopy Committee. Non-variceal upper gastrointestinal hemorrhage: guidelines. Gut 2002;51(Suppl):1-6.
16. Barkun A, Bardou M. Marshall JK; Nonvariceal Upper GI Bleeding Consensus Conference Group. Consensus recommendations for managing patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med 2003;139:843-57.
17. Schaffalitzky de Muckadell UB, Havelund T, Harling H, Boesby S, Snel P, et al. Effects of omeprazole on the outcome of endoscopically treated peptic ulcers. Scand J Gastroenterol 1997;32:320-7.
18. Andriulli A, Loperfido S, Focareta R, Leo P, Fornari F, Garripoli A, et al. High- versus low-dose proton pump inhibitors after endoscopic hemostasis in patient with peptic ulcer bleeding: a multicentre, randomized study. Am J Gastroenterol 2008;103:3011-8.
19. Peter S, Wilcox CM. Modern endoscopic therapy of peptic ulcer bleeding. Dig Dis 2008;26:291-9.
20. Laine L, McQuaid KR. Endoscopic therapy for bleeding ulcers: an evidence-based approach based on meta-analyses of randomized controlled trials. Clin Gastroenterol Hepatol 2009;7:33-47.
21. Khuroo MS, Farahat KL, Kagevi IE. Treatment with proton pump inhibitors in acute non-variceal upper gastrointestinal bleeding: a meta-analysis. J Gastroenterol Hepatol 2005;20:11-25. (Pubitemid 40143628)
22. Martin RM, Dunn NR, Freemantle S, Shakir S. The rates of common adverse events reported during treatment with proton pump inhibitors used in general practice in England: cohort studies. Br J Clin Pharmacol 2000;50:366-72.